Field Trip Health Ltd. (NASDAQ:FTRP) Sees Significant Decrease in Short Interest

Field Trip Health Ltd. (NASDAQ:FTRPGet Rating) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 216,900 shares, a decrease of 37.4% from the March 15th total of 346,500 shares. Based on an average trading volume of 142,700 shares, the short-interest ratio is currently 1.5 days. Currently, 0.7% of the shares of the company are sold short.

Hedge funds have recently bought and sold shares of the business. Commonwealth Equity Services LLC purchased a new stake in Field Trip Health during the fourth quarter valued at about $27,000. Bank of America Corp DE lifted its stake in Field Trip Health by 2,422.2% during the fourth quarter. Bank of America Corp DE now owns 22,700 shares of the company’s stock valued at $55,000 after buying an additional 21,800 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Field Trip Health during the third quarter valued at about $55,000. Virtu Financial LLC purchased a new stake in Field Trip Health during the fourth quarter valued at about $61,000. Finally, FinTrust Capital Advisors LLC acquired a new position in shares of Field Trip Health in the 3rd quarter valued at about $92,000. 13.71% of the stock is owned by institutional investors.

Several equities analysts have recently commented on the stock. Stifel Nicolaus lowered their price target on shares of Field Trip Health from C$11.50 to C$10.50 in a research report on Thursday, February 17th. Zacks Investment Research downgraded shares of Field Trip Health from a “hold” rating to a “sell” rating in a report on Wednesday, January 19th.

NASDAQ FTRP traded down $0.04 on Monday, reaching $1.37. The company’s stock had a trading volume of 302 shares, compared to its average volume of 137,800. Field Trip Health has a twelve month low of $0.98 and a twelve month high of $6.74. The company has a current ratio of 9.41, a quick ratio of 9.41 and a debt-to-equity ratio of 0.29. The business has a 50 day moving average price of $1.41.

Field Trip Health (NASDAQ:FTRPGet Rating) last issued its quarterly earnings results on Tuesday, February 15th. The company reported ($0.21) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.02). The business had revenue of $1.09 million for the quarter, compared to the consensus estimate of $1.35 million. As a group, research analysts predict that Field Trip Health will post -0.72 earnings per share for the current year.

Field Trip Health Company Profile (Get Rating)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules.

Recommended Stories

Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with's FREE daily email newsletter.